Cerebrospinal Fluid Amine Metabolites in Affective Illness: The Probenecid Technique
Abstract
Probenecid inhibits the removal of 5-HIAA and HVA (the major metabolites of serotonin and dopamine) from the cerebrospinal fluid. The accumulation of these metabolites following high doses of probenecid was studied in patients with affective illness in order to assess central amine function. The metabolite accumulation was increased by administering the appropriate precursors (which increase amine synthesis) and was decreased by administering specific synthesis inhibitors. Compared with controls, the depressed patients had low HVA accumulation, while addicts on methadone had low 5-HIAA accumulation. Within the group of depressed patients, HVA accumulation was higher in bipolar than in unipolar patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).